Maud Lemoine

6.9k total citations · 1 hit paper
122 papers, 3.5k citations indexed

About

Maud Lemoine is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Maud Lemoine has authored 122 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Epidemiology, 93 papers in Hepatology and 14 papers in Infectious Diseases. Recurrent topics in Maud Lemoine's work include Hepatitis C virus research (83 papers), Hepatitis B Virus Studies (81 papers) and Liver Disease Diagnosis and Treatment (73 papers). Maud Lemoine is often cited by papers focused on Hepatitis C virus research (83 papers), Hepatitis B Virus Studies (81 papers) and Liver Disease Diagnosis and Treatment (73 papers). Maud Lemoine collaborates with scholars based in France, United Kingdom and Gambia. Maud Lemoine's co-authors include Mark Thursz, Lawrence Serfaty, Yusuke Shimakawa, Shevanthi Nayagam, Karine Lacombe, Ramou Njie, Gibril Ndow, Jacqueline Capeau, Chantal Housset and Umberto D’Alessandro and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Maud Lemoine

117 papers receiving 3.5k citations

Hit Papers

EASL Clinical Practice Guidelines on the management of he... 2025 2026 2025 10 20 30
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
    2025 33 citations Maud Lemoine, Barbara Testoni et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maud Lemoine France 31 2.9k 2.3k 390 365 316 122 3.5k
Christopher Koh United States 31 2.2k 0.7× 1.8k 0.8× 224 0.6× 367 1.0× 225 0.7× 138 3.3k
Jee‐Fu Huang Taiwan 38 4.0k 1.4× 3.9k 1.7× 279 0.7× 432 1.2× 406 1.3× 290 5.4k
Daniele Prati Italy 39 3.5k 1.2× 2.5k 1.1× 637 1.6× 498 1.4× 624 2.0× 174 5.4k
Deepak Amarapurkar India 32 2.8k 1.0× 2.3k 1.0× 460 1.2× 1.0k 2.8× 447 1.4× 115 4.0k
S. Shalimar India 32 1.8k 0.6× 1.8k 0.8× 524 1.3× 905 2.5× 221 0.7× 236 3.4k
Vincent Di Martino France 35 4.1k 1.4× 4.2k 1.8× 812 2.1× 691 1.9× 324 1.0× 148 5.7k
Donald M. Jensen United States 36 3.7k 1.3× 3.7k 1.6× 594 1.5× 317 0.9× 227 0.7× 114 4.8k
Karen F. Murray United States 32 2.9k 1.0× 2.5k 1.1× 336 0.9× 1.3k 3.7× 581 1.8× 79 4.7k
Uchenna H. Iloeje United States 36 6.3k 2.2× 5.7k 2.5× 416 1.1× 333 0.9× 420 1.3× 77 7.2k
Thierry Thévenot France 25 2.0k 0.7× 1.9k 0.8× 173 0.4× 520 1.4× 294 0.9× 101 3.0k

Countries citing papers authored by Maud Lemoine

Since Specialization
Citations

This map shows the geographic impact of Maud Lemoine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maud Lemoine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maud Lemoine more than expected).

Fields of papers citing papers by Maud Lemoine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maud Lemoine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maud Lemoine. The network helps show where Maud Lemoine may publish in the future.

Co-authorship network of co-authors of Maud Lemoine

This figure shows the co-authorship network connecting the top 25 collaborators of Maud Lemoine. A scholar is included among the top collaborators of Maud Lemoine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maud Lemoine. Maud Lemoine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Michael X., Amelia Cook, Gibril Ndow, et al.. (2025). Quality of life in patients with HBV infection: A systematic review and meta-analysis. JHEP Reports. 7(4). 101312–101312. 2 indexed citations
2.
3.
Schmit, Nora, Shevanthi Nayagam, Maud Lemoine, et al.. (2023). Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia. Journal of Global Health. 13. 4004–4004. 2 indexed citations
4.
Nguyen, Liêm Binh Luong, Maud Lemoine, Gibril Ndow, et al.. (2023). Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet Global Health. 12(1). e66–e78. 8 indexed citations
5.
Ndow, Gibril, Yusuke Shimakawa, Saydiba Tamba, et al.. (2023). Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study. The Lancet Global Health. 11(9). e1383–e1392. 14 indexed citations
6.
Mohamed, Zameer, Nick Scott, Shevanthi Nayagam, et al.. (2021). Cost effectiveness of simplified HCV screening-and-treatment interventions for people who inject drugs in Dar-es-Salaam, Tanzania. International Journal of Drug Policy. 99. 103458–103458. 5 indexed citations
7.
8.
Yoshida, Kyoko, Yusuke Shimakawa, Mark Thursz, et al.. (2019). Clinical utility of TREAT-B score in African and non-African HBV-infected patients living in Europe. Journal of Hepatology. 70(6). 1295–1297. 6 indexed citations
9.
Nayagam, Shevanthi, Elisa Sicuri, Maud Lemoine, et al.. (2017). Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries. BMC Infectious Diseases. 17(S1). 692–692. 12 indexed citations
10.
Maurice, James, Amee B. Patel, Alasdair Scott, et al.. (2017). Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection. AIDS. 31(11). 1621–1632. 160 indexed citations
11.
Shimakawa, Yusuke, Kazuaki Takahashi, Gibril Ndow, et al.. (2015). Hepatitis E virus infection and acute‐on‐chronic liver failure in West Africa: a case–control study from The Gambia. Alimentary Pharmacology & Therapeutics. 43(3). 375–384. 16 indexed citations
12.
Shimakawa, Yusuke, Maud Lemoine, Harr Freeya Njai, et al.. (2015). Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia. Gut. 65(12). 2007–2016. 119 indexed citations
13.
Lemoine, Maud, Yusuke Shimakawa, Shevanthi Nayagam, et al.. (2015). The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 65(8). 1369–1376. 256 indexed citations
14.
Howell, Jessica, Nimzing G. Ladep, Maud Lemoine, Mark Thursz, & Simon D. Taylor‐Robinson. (2014). Hepatitis B in Sub-Saharan Africa. SHILAP Revista de lepidopterología. 7(3). 59–61. 7 indexed citations
15.
Lemoine, Maud, Pierre‐Marie Girard, Mark Thursz, & G Raguin. (2013). Dans l’ombre du VIH/SIDA : les maladies oubliées de l’Afrique sub-saharienne. Quels enjeux sanitaires ? Quelle responsabilité des bailleurs de fonds ?. OpenEdition (OpenEdition). 5(12). 4179–82. 2 indexed citations
16.
Lemoine, Maud, Harr Freeya Njai, Yusuke Shimakawa, et al.. (2013). 976 RURAL AND URBAN COMMUNITY-BASED HEPATITIS B SCREENING IN THE GAMBIA: ASSESSMENT OF LIVER DISEASE REVEALS A SIGNIFICANT PROPORTION OF ELIGIBLE PATIENTS FOR ANTIVIRAL THERAPY. Journal of Hepatology. 58. S402–S403. 2 indexed citations
17.
Lemoine, Maud & Patrick Ingiliz. (2012). Liver injury in HIV monoinfected patients: Should we turn a blind eye to it?. Clinics and Research in Hepatology and Gastroenterology. 36(5). 441–447. 7 indexed citations
18.
Lemoine, Maud, Lawrence Serfaty, & Jacqueline Capeau. (2011). From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients. Current Opinion in Infectious Diseases. 25(1). 10–16. 64 indexed citations
19.
Lemoine, Maud, Jacqueline Capeau, & Lawrence Serfaty. (2009). PPAR and Liver Injury in HIV‐Infected Patients. PPAR Research. 2009(1). 906167–906167. 11 indexed citations
20.
Lacombe, Karine, et al.. (2009). HIV/hepatitis B virus co-infection: current challenges and new strategies. Journal of Antimicrobial Chemotherapy. 65(1). 10–17. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Koh Breakdown of academic impact, for papers by Jee‐Fu Huang Breakdown of academic impact, for papers by Daniele Prati Breakdown of academic impact, for papers by Deepak Amarapurkar Breakdown of academic impact, for papers by S. Shalimar Breakdown of academic impact, for papers by Vincent Di Martino Breakdown of academic impact, for papers by Donald M. Jensen Breakdown of academic impact, for papers by Karen F. Murray Breakdown of academic impact, for papers by Uchenna H. Iloeje Breakdown of academic impact, for papers by Thierry Thévenot
Rankless by CCL
2026